This technology enables precise, water-based modification of proteins at their C-terminus using a single, easily removable reagent, allowing attachment of various functional groups while preserving the protein’s natural structure and function for therapeutic and research applications.
Background: Protein engineering is a rapidly evolving field that underpins advances in therapeutics, diagnostics, and biotechnology. Proteins and polypeptides serve as the foundation for many modern medicines, including hormones, antibodies, and enzymes. However, their utility often depends on the ability to modify them in precise, site-specific ways—such as attaching drugs, imaging agents, or other functional groups—without disrupting their natural structure or function. Achieving such modifications, especially at the protein’s C-terminus, is crucial for improving drug efficacy, stability, and targeting, as well as for creating homogeneous bioconjugates for research and clinical use. The demand for efficient, reliable, and biocompatible protein modification strategies continues to grow as the pharmaceutical and biotechnology industries seek to develop next-generation protein-based therapeutics and diagnostics. Despite significant progress, current approaches to protein modification face several persistent challenges. Many established methods require pre-functionalization steps or the introduction of non-native reactive groups, which can be labor-intensive and risk altering the protein’s native folding or biological activity. Additionally, these techniques often rely on harsh reaction conditions, such as organic solvents or elevated temperatures, which can denature sensitive proteins and limit their applicability to therapeutic molecules. Achieving site-specificity—particularly at the C-terminus—remains difficult, leading to heterogeneous products that complicate downstream processing and regulatory approval. Purification of modified proteins is further complicated by the presence of residual reagents or by-products, increasing the risk of contamination and reducing overall yield. These limitations underscore the need for new methods that enable selective, efficient, and gentle modification of proteins in their native state, with minimal impact on their structure and function.
Technology Overview: This technology enables the selective chemical modification of protein and polypeptide backbones specifically at their C-terminus, using a single, water-soluble reagent that functions efficiently in aqueous environments. The process allows for direct attachment of diverse functional groups—including small molecules, polypeptides, proteins, and carbohydrates—to the C-terminal amide bond, all while preserving the protein’s native structure and function. The method requires no pre-functionalization or introduction of special reactive groups, and operates under mild, water-based conditions that are compatible with sensitive biomolecules. After the reaction, the reagent and any by-products are easily removed, resulting in stable, canonical amide bonds that mimic natural peptide linkages. This streamlined approach simplifies purification and supports the creation of tailored bioconjugates for applications in drug development, protein engineering, and diagnostics. What differentiates this technology is its unique combination of specificity, simplicity, and biocompatibility. Unlike traditional protein modification methods that often require harsh conditions, pre-functionalization, or risk disrupting protein folding, this solution offers a gentle, highly selective approach that targets only the C-terminus. The ability to operate entirely in water preserves the biological activity and stability of the protein, which is crucial for therapeutic efficacy and safety. Its versatility in attaching a wide array of functional groups expands the possibilities for creating homogeneous, site-specific bioconjugates, addressing a major challenge in protein engineering. The ease of by-product removal and the formation of stable amide bonds further enhance its practicality and reliability, making it a significant advancement for researchers and developers seeking efficient, reproducible, and biocompatible protein modifications.
https://suny.technologypublisher.com/files/sites/adobestock_571000360.jpeg Photo for reference only, not a depiction of the invention.
Advantages: • Enables selective, site-specific modification of protein C-terminus without pre-functionalization • Preserves native protein structure and biological function • Operates under mild, aqueous conditions compatible with sensitive proteins • Supports attachment of diverse functional groups (small molecules, peptides, proteins, carbohydrates) • Produces stable, canonical amide bonds ensuring biocompatibility • Facilitates easy removal of reagent and by-products, simplifying purification • Broadly applicable for therapeutic protein modification, drug development, and diagnostics • Demonstrated effectiveness on clinically relevant proteins like insulin and semaglutide
Applications: • Therapeutic protein drug modification • Homogeneous antibody-drug conjugate creation • Site-specific diagnostic probe labeling • Protein engineering for research tools • Custom bioconjugate vaccine development
Intellectual Property Summary: Patent pending
Stage of Development: TRL 3
Licensing Status: This technology is available for licensing.